A phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants -: A North American Brain Tumor Consortium report Article

Chang, SM, Kuhn, JG, Robins, HI et al. (2001). A phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants -: A North American Brain Tumor Consortium report . CANCER, 91(2), 417-422. 10.1002/1097-0142(20010115)91:2<417::AID-CNCR1016>3.0.CO;2-9

cited authors

  • Chang, SM; Kuhn, JG; Robins, HI; Schold, SC; Spence, AM; Berger, MS; Mehta, MP; Pollack, IF; Rankin, C; Prados, MD

sustainable development goals

authors

publication date

  • January 15, 2001

published in

keywords

  • INFUSION
  • Life Sciences & Biomedicine
  • METASTATIC BREAST-CANCER
  • Oncology
  • SALVAGE CHEMOTHERAPY
  • Science & Technology
  • TAXOL
  • anticonvulsant
  • chemotherapy
  • malignant glioma
  • paclitaxel

publisher

  • WILEY-LISS

start page

  • 417

end page

  • 422

volume

  • 91

issue

  • 2